Cargando…
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
AIMS: To determine whether fibrin clot properties are associated with clinical outcomes following acute coronary syndrome (ACS). METHODS AND RESULTS: Plasma samples were collected at hospital discharge from 4354 ACS patients randomized to clopidogrel or ticagrelor in the PLATelet inhibition and pati...
Autores principales: | Sumaya, Wael, Wallentin, Lars, James, Stefan K, Siegbahn, Agneta, Gabrysch, Katja, Bertilsson, Maria, Himmelmann, Anders, Ajjan, Ramzi A, Storey, Robert F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019045/ https://www.ncbi.nlm.nih.gov/pubmed/29390064 http://dx.doi.org/10.1093/eurheartj/ehy013 |
Ejemplares similares
-
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
por: Sumaya, Wael, et al.
Publicado: (2020) -
Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial
por: Gregersen, Ida, et al.
Publicado: (2020) -
Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial
por: Ueland, Thor, et al.
Publicado: (2018) -
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
por: Åkerblom, Axel, et al.
Publicado: (2019) -
Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
por: Storey, Robert F., et al.
Publicado: (2014)